Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BJSE:920504's Quick Ratio is ranked better than 73.71% of 852
companies
in the Medical Devices & Instruments industry
Industry Median: 1.9
vs BJSE:920504: 3.72
Shanghai Boxun Medical Biological Instrument (BJSE:920504) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Shanghai Boxun Medical Biological Instrument Quick Ratio Related Terms
Shanghai Boxun Medical Biological Instrument Quick Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai Boxun Medical Biological Instrument Quick Ratio Chart
Shanghai Boxun Medical Biological Instrument Annual Data
BJSE:920504 vs ISRG, BDX, MDLN: Quick Ratio Comparison
For the Medical Instruments & Supplies subindustry, Shanghai Boxun Medical Biological Instrument's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai Boxun Medical Biological Instrument Quick Ratio vs Medical Devices & Instruments Industry
Shanghai Boxun Medical Biological Instrument Quick Ratio Calculation
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai Boxun Medical Biological Instrument (BJSE:920504) has a Quick Ratio of 3.72 as of Mar. 2026. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Shanghai Boxun Medical Biological Instrument and its competitors. This is 89% above median its historical median of 1.97. Over the past decade, Shanghai Boxun Medical Biological Instrument's Quick Ratio has ranged from 0.71 to 4.45. According to the industry distribution chart, Shanghai Boxun Medical Biological Instrument ranks #224 out of 852 companies in the Medical Devices & Instruments industry, placing it in the top 26.3%.
Is Shanghai Boxun Medical Biological Instrument's Quick Ratio too high?
Shanghai Boxun Medical Biological Instrument's current Quick Ratio of 3.72 is 89% above median its 10-year median of 1.97. Over the past 10 years, this metric has ranged from a low of 0.71 to a high of 4.45. The Medical Devices & Instruments industry median Quick Ratio is 1.90. Shanghai Boxun Medical Biological Instrument's value of 3.72 is 95.8% above this industry median. Based on the distribution chart, Shanghai Boxun Medical Biological Instrument ranks #224 out of 852 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Shanghai Boxun Medical Biological Instrument has a GF Score™ of 69/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai Boxun Medical Biological Instrument's Quick Ratio compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Shanghai Boxun Medical Biological Instrument ranks #224 out of 852 companies for Quick Ratio. This puts Shanghai Boxun Medical Biological Instrument in the upper half of its industry. The industry median Quick Ratio is 1.90. Shanghai Boxun Medical Biological Instrument's value of 3.72 is 95.8% above this benchmark. Historically, Shanghai Boxun Medical Biological Instrument's own Quick Ratio has ranged from 0.71 to 4.45 over the past decade. While the company's 10-year median is 1.97 vs. the industry median of 1.90, Shanghai Boxun Medical Biological Instrument has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Medical Devices & Instruments company?
The median Quick Ratio among Medical Devices & Instruments companies is 1.90, based on 852 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shanghai Boxun Medical Biological Instrument's current Quick Ratio of 3.72 is 95.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Shanghai Boxun Medical Biological Instrument and its competitors. For the Medical Devices & Instruments industry, the median Quick Ratio is 1.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghai Boxun Medical Biological Instrument's current Quick Ratio is 3.72, which is 89% above median its own 10-year median of 1.97. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Boxun Medical Biological Instrument stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Boxun Medical Biological Instrument (BJSE:920504) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥19.47, compared to a current price of ¥17.11 — trading 12.1% below its estimated fair value. The current Quick Ratio is 3.72, which is 89% above median its 10-year median of 1.97 and 95.8% above the Medical Devices & Instruments industry median of 1.90. Shanghai Boxun Medical Biological Instrument's overall GF Score™ is 69/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Shanghai Boxun Medical Biological Instrument (BJSE:920504), the current Quick Ratio is 3.72 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shanghai Boxun Medical Biological Instrument (BJSE:920504) Overvalued in 2026?
Based on GuruFocus' analysis, Shanghai Boxun Medical Biological Instrument stock appears to be undervalued.
The current stock price of ¥17.11 is trading 12.1% below its estimated GF Value™ of ¥19.47.
GuruFocus considers Shanghai Boxun Medical Biological Instrument to be Modestly Undervalued.
Key valuation signals for BJSE:920504:
Quick Ratio: 3.72 (89% above median its 10-year median of 1.97)
GF Value™: ¥19.47 vs. price of ¥17.11 (12.1% below fair value)
Industry Position: 95.8% above the Medical Devices & Instruments median (#224 of 852)
No single metric tells the full story. See the BJSE:920504 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shanghai Boxun Medical Biological Instrument Corp is engaged in Research and development, production, sales, and service of laboratory equipment and life science instruments. The company's main products are temperature and humidity control series products, high-pressure sterilization series products, and purification safety series products, etc.
69GF Score
Get the complete analysis for BJSE:920504
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BJSE:920504 has been successfully added to your 
